P2Y12 platelet inhibition in clinical practice-Reference-Cited by-同舟云学术

P2Y12 platelet inhibition in clinical practice

Published:2011-12-20 Issue:2 Volume:33 Page:143-153
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Damman Peter,Woudstra Pier,Kuijt Wichert J.,de Winter Robbert J.,James Stefan K.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-011-0667-5

Reference65 articles.

1. Jennings LK (2009) Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102(2):248–257

2. Wijns W, Kolh P, Danchin N, et al (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J Sep 25

3. Silber S, Albertsson P, Avilés FF et al (2005) Guidelines for percutaneous coronary interventions. Eur Heart J 26(8):804–847

4. Meadows TA, Bhatt DL (2007) Clinical aspects of platelet inhibitors and thrombus formation. Circ Res 100(9):1261–1275

5. Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123(23):2736–2747

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Ticagrelor Versus Clopidogrel After Off‐Pump Coronary Artery Bypass Grafting on Postoperative Atrial Fibrillation: A Cohort Study;Journal of the American Heart Association;2024-08-20

2. High-mobility group box 1 increases platelet surface P2Y₁₂ and platelet activation in sickle cell disease;JCI INSIGHT;2024

3. GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease;European Heart Journal - Cardiovascular Pharmacotherapy;2024-03-07

4. Pharmacogenomic Biomarkers in Coronary Artery Disease: A Narrative Review;Biomarkers in Medicine;2024-03

5. Antithrombotic Therapy for Heterogeneous Causes of Stroke;Ischemic Stroke Therapeutics;2024